Sinofn Health Sinofn Health

OEM SINOFN Health All About Supplements Manufacturers & Supplier

Precision Nutraceutical Solutions | Global Expertise | Scientific Excellence

The Evolution of Global Supplement Manufacturing

In the contemporary wellness landscape, the supplement industry has undergone a paradigm shift from mass-market production to precision-driven nutraceutical formulation. As a leading OEM/ODM entity, SINOFN Health sits at the intersection of biochemical research and industrial scalability. The global industry is currently facing unprecedented demand for bioavailability, ingredient purity, and regulatory compliance. We bridge the gap between academic research (pioneered by the Chinese Academy of Sciences) and commercial accessibility, ensuring that global brands can launch products with clinical-grade reliability.

Macro Industry Status & Challenges

Today’s supplement market is hyper-competitive. Brands are struggling with rising raw material costs, tightening FDA/EFSA/TGA regulations, and consumer skepticism regarding transparency. SINOFN addresses these by implementing Blockchain-traceable batch management and high-precision formulation technology, enabling our partners to navigate the complexities of international markets with confidence. Whether it is NMN, PQQ, or metabolic support for PKU, our supply chain ensures integrity from source to shelf.

About SINOFN: Science-Driven OEM

SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012. We operate as the trading hub for global partners seeking premium, science-driven contract manufacturing services.

R&D Team: Building Excellent Product Quality

Our commitment to E-E-A-T is anchored in our elite research team. By cooperating with top universities, we maintain a robust innovation pipeline.

Medical Innovation Director

Dr. Tan Shengjie (Ph.D Peking University)

15+ years in metabolic disorder formulations.

R&D Lead

Dr. Zhang Ying (CAS Postdoc)

Specialist in bioactive compound delivery systems.

Formulation Director

Hans van Dijk (Netherlands)

EU regulatory specialist in nutraceutical delivery tech.

Technology Roadmap & Future Prospects

Our R&D roadmap focuses on three pillars: Bioavailability Optimization, Controlled Release Mechanisms, and Clean-Label Formulation. We are moving beyond traditional powder and capsule formats, investing heavily in nano-emulsification for oral liquids and high-absorption metabolic support formulas (like our cAMP Jujube extract). Looking forward, SINOFN is integrating AI-driven stability testing and real-time clinical monitoring to provide our partners with future-proof products that meet the evolving definitions of health and wellness.

Our Factory Capabilities

GMP Production

10+ dedicated lines, ISO 22000, HACCP, FSSC 22000 certified.

QA & Testing

HPLC/GC-MS contaminant screening, microbiological safety testing.

Global Standards

Strict adherence to HALAL, ISO, and regional regulatory frameworks.

Frequently Asked Questions

Where are your facilities located?

We operate state-of-the-art facilities in China, optimized for global logistics and high-capacity production. Our Shanghai hub manages international trade and customer service to ensure seamless communication.

Can you support R&D and rapid prototyping?

Absolutely. We provide pilot-scale prototyping for tablets, capsules, and liquids, enabling your brand to test formulations before full-scale manufacturing runs.

How do you ensure local regulatory compliance?

We work with international regulatory experts to ensure that our formulations and documentation align with target market requirements, whether FDA (USA), EFSA (EU), or local health authority guidelines.